Uncategorised - European Medical Journal

Evolving Opportunistic Infections in Cancer Therapy

Learn how modern cancer treatments like immunotherapy and CAR-T cells are shifting the risk of opportunistic infections from traditional…

Rome V and Functional Dyspepsia

Watch expert-led discussions on the latest Rome V guidance for functional dyspepsia, from diagnosis and biology to evidence-based…

FDA office building

J&J wins FDA nod for Imaavy in rare blood disorder

The US regulator has cleared Johnson & Johnson’s Imaavy (nipocalimab) for warm autoimmune haemolytic anaemia, or wAIHA.

Person smoking while driving

Smoking Exposure Doubles Sudden Cardiac Death Risk

Long-term follow-up data showed a strong association between cumulative smoking exposure and sudden cardiac death risk.

Globe with pills around it

National Wealth Linked to Biologic Retention in Spondyloarthritis

A 13-country study found that patients in wealthier nations were more likely to discontinue biologic therapy for PsA and axSpA, despite generally better access to treatment.

Month in pharma news, explained

Month in pharma news, explained – August 2026

From the AZ-BMS merger rumour that rattled markets to a double UK approval for Eli Lilly’s weight loss pill, there’s plenty to discover.

person with vitiligo

Topical Ruxolitinib Shows Real-World Vitiligo Benefits

A large real-world study found that topical ruxolitinib was associated with progressive repigmentation and improvements in mental health and quality of life.

cervical screening tests for hpv

NHS Rolls Out Free At-Home Cervical Screening Tests to UK Women

Millions of women can now access free NHS at-home HPV tests as a new cervical cancer screening scheme rolls out across England.

Female doctors checks the breast of another woman for signs of cancer

New Target Identified to Limit Triple-Negative Breast Cancer Spread

Researchers identify a targetable molecular pathway that may help drive metastasis in triple-negative breast cancer.

Hema Now: What’s Next in Leukaemia Treatment?

Daniel DeAngelo, Chief of the Division of Leukemia, Dana-Farber Cancer Institute; and Professor of Medicine, Harvard Medical School…